BioBridgeXAll companies

Hillhurst Biopharmaceuticals, Inc.

Biotechnology company · Montrose, California, United States

Hillhurst Biopharmaceuticals, Inc. is a biotechnology company headquartered in Montrose, California, United States. It has received 13 US government small-business research awards (SBIR/STTR) from health agencies, $12 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1.8 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Hillhurst Biopharmaceuticals at a glance

Typebiotechnology company
HeadquartersMontrose, California, United States
Employees (per SBIR records)1
SEC CIK1994336

What does Hillhurst Biopharmaceuticals do?

US government research funding

13 SBIR/STTR small-business research awards from US health agencies, $12.1 million in total (2015 to 2024). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.8 million sold (2023).

Frequently asked questions about Hillhurst Biopharmaceuticals

Where is Hillhurst Biopharmaceuticals headquartered?

Hillhurst Biopharmaceuticals, Inc. is headquartered in Montrose, California, United States.

What does Hillhurst Biopharmaceuticals do?

Hillhurst Biopharmaceuticals, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.